T. Rowe Price Health Care ETF (TMED)
NASDAQ: TMED · Real-Time Price · USD
29.93
+0.18 (0.60%)
Dec 15, 2025, 4:00 PM EST - Market closed
TMED Holdings Information
TMED is an equity ETF with a total of 101 individual holdings. The top holdings are Eli Lilly and Company stock at 13.76%, UnitedHealth Group at 7.56%, Abbott Laboratories at 4.54%, Gilead Sciences at 3.93%, and Thermo Fisher Scientific at 3.74%.
Total Holdings
25
Top 10 Percentage
49.81%
Asset Class
Equity
ETF Category
Health
Assets
16.32M
PE Ratio
26.06
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 13.76% |
| 2 | UNH | UnitedHealth Group Incorporated | 7.56% |
| 3 | ABT | Abbott Laboratories | 4.54% |
| 4 | GILD | Gilead Sciences, Inc. | 3.93% |
| 5 | TMO | Thermo Fisher Scientific Inc. | 3.74% |
| 6 | ABBV | AbbVie Inc. | 3.68% |
| 7 | ISRG | Intuitive Surgical, Inc. | 3.66% |
| 8 | DHR | Danaher Corporation | 3.21% |
| 9 | GVMXX | State Street U.S. Government Money Market Portfolio | 3.02% |
| 10 | BDX | Becton, Dickinson and Company | 2.73% |
| 11 | CYTK | Cytokinetics, Incorporated | 2.42% |
| 12 | ELAN | Elanco Animal Health Incorporated | 2.29% |
| 13 | MDT | Medtronic plc | 1.92% |
| 14 | SYK | Stryker Corporation | 1.80% |
| 15 | COR | Cencora, Inc. | 1.71% |
| 16 | CVS | CVS Health Corporation | 1.52% |
| 17 | ASND | Ascendis Pharma A/S | 1.50% |
| 18 | BIIB | Biogen Inc. | 1.47% |
| 19 | ACLX | Arcellx, Inc. | 1.44% |
| 20 | DYN | Dyne Therapeutics, Inc. | 1.39% |
| 21 | A | Agilent Technologies, Inc. | 1.30% |
| 22 | HUM | Humana Inc. | 1.22% |
| 23 | DXCM | DexCom, Inc. | 1.17% |
| 24 | MTD | Mettler-Toledo International Inc. | 1.11% |
| 25 | COO | The Cooper Companies, Inc. | 1.10% |
As of Dec 12, 2025